PMV Pharmaceuticals, Inc
Symbol: PMVP (NASDAQ)
1.38
▼ (-5.10%) -0.074
Company Description:
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
Key Stats
- Today's Open: $1.44
- Today's High: $1.49
- Today's Low: $1.33
- Today's Volume: 462.24K
- Yesterday Close: $1.45
- Yesterday High: $1.51
- Yesterday Low: $1.42
- Yesterday Volume: 387.19K
- Last Min Volume: 0
- Last Min High: $1.396
- Last Min Low: $1.376
- Last Min VWAP: $0
Company Profile
- Name: PMV Pharmaceuticals, Inc
- Website: https://www.pmvpharma.com
- Listed Date: 2020-09-25
- Location: PRINCETON, NJ
- Market Status: Active
- CIK Number: 0001699382
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $76.84M
- Round Lot: 100
- Outstanding Shares: 52.99M
- Asset Type: CS
RECENT FILINGS FOR PMVP
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-23 | SCHEDULE 13G | View |
| 2025-09-12 | 4 | View |
| 2025-09-10 | 144 | View |
| 2025-09-10 | 8-K | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-13 | SCHEDULE 13G/A | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 8-K | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
Latest News on PMVP